Affimer proteins inhibit immune complex binding to FcγRIIIa with high specificity through competitive and allosteric modes of action
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Affimer proteins inhibit immune complex binding to FcγRIIIa with high specificity through competitive and allosteric modes of action
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 1, Pages E72-E81
Publisher
Proceedings of the National Academy of Sciences
Online
2017-12-16
DOI
10.1073/pnas.1707856115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Affimer proteins are versatile and renewable affinity reagents
- (2017) Christian Tiede et al. eLife
- Fc-gamma receptors: Attractive targets for autoimmune drug discovery searching for intelligent therapeutic designs
- (2016) Carlos J. Bosques et al. AUTOIMMUNITY REVIEWS
- Label-free electrochemical impedance biosensor to detect human interleukin-8 in serum with sub-pg/ml sensitivity
- (2016) R. Sharma et al. BIOSENSORS & BIOELECTRONICS
- Systematic Targeting of Protein–Protein Interactions
- (2016) Ashley E. Modell et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Exploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologies
- (2015) Hannah F. Kyle et al. Molecular BioSystems
- Phage display selected magnetite interacting Adhirons for shape controlled nanoparticle synthesis
- (2015) Andrea E. Rawlings et al. Chemical Science
- Modulators of Protein–Protein Interactions
- (2014) Lech-Gustav Milroy et al. CHEMICAL REVIEWS
- Kinase inhibitors: The next generation of therapies in the treatment of rheumatoid arthritis
- (2014) Lindsey A. MacFarlane et al. International Journal of Rheumatic Diseases
- Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications
- (2014) Christian Tiede et al. PROTEIN ENGINEERING DESIGN & SELECTION
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Protein–protein interactions as druggable targets: recent technological advances
- (2013) Alicia P Higueruelo et al. CURRENT OPINION IN PHARMACOLOGY
- Effects of Fostamatinib (R788), an Oral Spleen Tyrosine Kinase Inhibitor, on Health-related Quality of Life in Patients with Active Rheumatoid Arthritis: Analyses of Patient-reported Outcomes from a Randomized, Double-blind, Placebo-controlled Trial
- (2013) M. E. Weinblatt et al. JOURNAL OF RHEUMATOLOGY
- Towards automated crystallographic structure refinement withphenix.refine
- (2012) Pavel V. Afonine et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Evolutionary History of Copy-Number-Variable Locus for the Low-Affinity Fcγ Receptor: Mutation Rate, Autoimmune Disease, and the Legacy of Helminth Infection
- (2012) Lee R. Machado et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Confirmation of association ofFCGR3Bbut notFCGR3Acopy number with susceptibility to autoantibody positive rheumatoid arthritis
- (2012) James I. Robinson et al. HUMAN MUTATION
- Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond
- (2012) P. Mark Hogarth et al. NATURE REVIEWS DRUG DISCOVERY
- FcγRIIIa Expression on Monocytes in Rheumatoid Arthritis: Role in Immune-Complex Stimulated TNF Production and Non-Response to Methotrexate Therapy
- (2012) Dawn L. Cooper et al. PLoS One
- Structural biology and drug discovery for protein–protein interactions
- (2012) Harry Jubb et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- High throughput construction and small scale expression screening of multi-tag vectors in Escherichia coli
- (2011) Louise E. Bird METHODS
- Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose
- (2011) C. Ferrara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
- (2009) J. W. Friedberg et al. BLOOD
- TRITON: a graphical tool for ligand-binding protein engineering
- (2008) Martin Prokop et al. BIOINFORMATICS
- Heterogeneity of Monoclonal Antibodies Revealed by Charge-Sensitive Methods
- (2008) J. Vlasak et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Copy number ofFCGR3B,which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake
- (2008) Lisa C. Willcocks et al. JOURNAL OF EXPERIMENTAL MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started